This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Dec 13;9(2):68.

doi: 10.1038/nrcardio.2011.201.

Anticoagulation therapy: Idrabiotaparinux noninferior to warfarin for long-term treatment of pulmonary embolism

PMID: 22158081
DOI: 10.1038/nrcardio.2011.201

Comment

Anticoagulation therapy: Idrabiotaparinux noninferior to warfarin for long-term treatment of pulmonary embolism

Gregory B Lim. Nat Rev Cardiol. 2011.

. 2011 Dec 13;9(2):68.

doi: 10.1038/nrcardio.2011.201.

Author

PMID: 22158081
DOI: 10.1038/nrcardio.2011.201

No abstract available

PubMed Disclaimer

Comment on

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators. Büller HR, et al. Lancet. 2012 Jan 14;379(9811):123-9. doi: 10.1016/S0140-6736(11)61505-5. Epub 2011 Nov 28. Lancet. 2012. PMID: 22130488 Clinical Trial.

References

1. Lancet. 2012 Jan 14;379(9811):123-9 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.